Research
Sector Report

Q1 2022: the outlook for e-pharmacies

  • Private Equity
  • Healthcare
  • North America

The COVID-19 pandemic has been a catalyst for e-pharmacy adoption and Forum Interviews suggest that once patients switch from brick-and-mortar outlets, they are unlikely to revert. Experts say this budding market is seeking to capitalise on traditional pharmacy’s slow-moving approach to innovation, low Net Promoter Scores and high error rates. 

The COVID-19 pandemic has been a catalyst for e-pharmacy adoption and Forum Interviews suggest that once patients switch from brick-and-mortar outlets, they are unlikely to revert. Experts say this budding market is seeking to capitalise on traditional pharmacy’s slow-moving approach to innovation, low Net Promoter Scores and high error rates. 

Although e-pharmacy’s biggest competitors are still by far the brick-and-mortar incumbents, a former director at Alto Pharmacy told us that competition is heating up at the “second tier” e-pharmacy level, signalling that these players are gaining ground. “I would say yes, in terms of these legacy pharmacies, are they worried? They’re definitely worried.” 

Read More

Submit your details to access the latest Quarterly Trends Report from Third Bridge.